Bridgefront Capital’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,714
| Closed | -$267K | – | 603 |
|
|
2025
Q1 | $267K | Buy |
+1,714
| New | +$267K | 0.08% | 429 |
|
|
2022
Q1 | – | Sell |
-1,708
| Closed | -$230K | – | 268 |
|
|
2021
Q4 | $230K | Buy |
1,708
+416
| +32% | +$56K | 0.22% | 202 |
|
|
2021
Q3 | $206K | Buy |
+1,292
| New | +$206K | 0.21% | 239 |
|